Main Line biotech firm advancing technology to help diagnose, treat prostate …

Main Line biotech firm advancing technology to help diagnose, treat prostate …

ProstaGene is developing gene-based technology to diagnose and treat prostate cancer. iStockphoto. ProstaGene has raised $400,000 from private investors to support commercialization of a gene-based test to help guide prostate cancer treatment.

(Visited 4 times, 1 visits today)
1
Like
Save

Comments

Write a comment

*